regorafenib,fruquintinib
hutchmed,bayer
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'fresco-2', 'regorafenib', 'fruquintinib']
fresco-2 : global demonstration of fruquintinib efficacy in heavily pretreated mcrc, including vegfi (96%), regorafenib (48%) and/or tas102 (91%). good news for such an unmet need! 
GI oncologist, MD, PhD (FRA)